Tessera
Folgen

Hannes Hagström

@liverepi.bsky.social

Professor in gastroenterology and hepatology @KarolinskaInst. Adjunct editor @JInternMed. Interest in liver disease, especially MASLD/MASH, public health, epidemiology.

35 Posts488 Follower129 Folgt
Otto English@ottoenglish.bsky.social · 12mo ago

Nathan Gill is no fringe politician. He was the leader of the Reform Party and before that UKIP in Wales. A Brexit Party MEP. A friend and ally of Nigel Farage, who in 2016 called him: "terrific," and "as honest as the day is long." This is a MASSIVE story www.bbc.co.uk/news/article...

Reform UK's ex-Wales leader Nathan Gill admits pro-Russia bribery

Nathan Gill admits eight charges of bribery while being a Member of the European Parliament.

bbc.co.uk

Hannes Hagström@liverepi.bsky.social · last yr.

New review from us: Clinical Utility of Non-Invasive Tests for Liver Fibrosis in People Living With Alpha-1 Antitrypsin Deficiency. Happy to coauthor with leading experts and led by Joost Boeckmans. Nice start of a new project on AATD using Swedish data. onlinelibrary.wiley.com/doi/10.1111/...

Clinical Utility of Non‐Invasive Tests for Liver Fibrosis in People Living With Alpha‐1 Antitrypsin Deficiency

Severe alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition characterised by low systemic levels of alpha-1 antitrypsin due to its retention in the liver. Consequently, it predisposes in...

onlinelibrary.wiley.com

Elin Bjarnegård@elinbja.bsky.social · last yr.

Are you a researcher active outside of Europe who might consider coming to Sweden? Check out this @vetenskapsradet.bsky.social grant for recruitment of international visiting researchers! www.vr.se/english/appl...

Grant for recruiting international visiting researchers to Sweden

The purpose of the grant is to provide higher education institutions and other research organisations the opportunity to develop and strengthen a research field by recruiting a distinguished researche...

vr.se

Hannes Hagström@liverepi.bsky.social · last yr.

New from Juan Vaz in our group: www.sciencedirect.com/science/arti... In >5400 patients with primary liver cancer (HCC), those with lower socio-economic parameters such as income levels have more advanced tumors at diagnosis, less frequently receive curative treatments and have poorer prognosis.

Socioeconomic inequalities in diagnostics, care and survival outcomes for hepatocellular carcinoma in Sweden: a nationwide cohort study

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. This study evaluates how strongly socioeconomic factors assoc…

sciencedirect.com

Hannes Hagström@liverepi.bsky.social · last yr.

New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016... Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!

Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden

Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...

journal-of-hepatology.eu

Hannes Hagström@liverepi.bsky.social · last yr.

Interesting study from Alina Allen's group: pubmed.ncbi.nlm.nih.gov/40105977/ Reassuring that MASLD diagnosis identified through screening led to weight loss and no major issues with increased anxiety.

Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease - PubMed

Screening for diseases can have psychological impacts, such as anxiety, and requires acceptability from the population to be effective. This study examined the perspectives on the benefits and harms o...

pubmed.ncbi.nlm.nih.gov

Hannes Hagström@liverepi.bsky.social · last yr.

Simultaneous liver transplant and sleeve gastrectomy provides durable weight loss, improves metabolic syndrome and reduces allograft steatosis: pubmed.ncbi.nlm.nih.gov/40089069/ Interesting. Time for a RCT? #liversky @jhepatology.bsky.social

Simultaneous liver transplant and sleeve gastrectomy provides durable weight loss, improves metabolic syndrome and reduces allograft steatosis - PubMed

LTSG results in sustained weight loss, resolution of diabetes and hypertension, and reduced recurrence of steatosis and possibly fibrosis compared to LT alone. It confers no increase in mortality or g...

pubmed.ncbi.nlm.nih.gov